151 related articles for article (PubMed ID: 8726804)
1. Relevance of circadian cell kinetics in the timing of chemotherapy in animal tumors.
Focan C
In Vivo; 1995; 9(6):573-81. PubMed ID: 8726804
[TBL] [Abstract][Full Text] [Related]
2. Marker rhythms for cancer chronotherapy. From laboratory animals to human beings.
Focan C
In Vivo; 1995; 9(4):283-98. PubMed ID: 8555427
[TBL] [Abstract][Full Text] [Related]
3. Circadian cell kinetics in humans. Aspects related to cancer chemotherapy.
Smaaland R; Laerum OD; Abrahamsen JF
In Vivo; 1995; 9(6):529-37. PubMed ID: 8726798
[TBL] [Abstract][Full Text] [Related]
4. [Chronobiology and cancer].
Lévi F
Pathol Biol (Paris); 1987 Jun; 35(6):960-8. PubMed ID: 3306577
[TBL] [Abstract][Full Text] [Related]
5. [Chronopharmacology and chronotherapy of cancers].
Lévi F
Pathol Biol (Paris); 1996 Sep; 44(7):631-44. PubMed ID: 8977920
[TBL] [Abstract][Full Text] [Related]
6. Identifying mechanisms of chronotolerance and chronoefficacy for the anticancer drugs 5-fluorouracil and oxaliplatin by computational modeling.
Altinok A; Lévi F; Goldbeter A
Eur J Pharm Sci; 2009 Jan; 36(1):20-38. PubMed ID: 19041394
[TBL] [Abstract][Full Text] [Related]
7. Cell kinetics and chemotherapy: a critical review.
Tannock I
Cancer Treat Rep; 1978 Aug; 62(8):1117-33. PubMed ID: 356975
[TBL] [Abstract][Full Text] [Related]
8. Circadian rhythms and cancer chemotherapy.
Focan C
Pharmacol Ther; 1995; 67(1):1-52. PubMed ID: 7494859
[TBL] [Abstract][Full Text] [Related]
9. [The circadian-timing system: a determinant of drug activity and a target of anticancer treatments].
Lévi F
Ann Pharm Fr; 2008 Jun; 66(3):175-84. PubMed ID: 18706346
[TBL] [Abstract][Full Text] [Related]
10. Chronopharmacology and its impact on antihypertensive treatment.
Lemmer B
Acta Physiol Pharmacol Bulg; 1999; 24(3):71-80. PubMed ID: 10736610
[TBL] [Abstract][Full Text] [Related]
11. Biological perspectives on circadian cancer therapy.
Wood PA; Hrushesky WJ
J Infus Chemother; 1995; 5(4):182-90. PubMed ID: 8934723
[TBL] [Abstract][Full Text] [Related]
12. X-irradiation chronosensitivity and circadian rhythmic proliferation in healthy and sarcoma-carrying rats' bone marrow.
Blank MA; Gushchin VA; Halberg F; Portela A; Cornélissen G
In Vivo; 1995; 9(4):395-400. PubMed ID: 8555440
[TBL] [Abstract][Full Text] [Related]
13. Synthetic adrenocorticotropin for optimizing murine circadian chronotolerance for adriamycin.
Levi F; Halberg F; Haus E; Sanchez de la Peña S; Sothern RB; Halberg E; Hrushesky W; Brown H; Scheving LE; Kennedy BJ
Chronobiologia; 1980; 7(2):227-44. PubMed ID: 6253239
[TBL] [Abstract][Full Text] [Related]
14. Circadian and infradian aspects of the cell cycle: from past to future.
Laerum OD; Smaaland R
Chronobiologia; 1989; 16(4):441-53. PubMed ID: 2697525
[TBL] [Abstract][Full Text] [Related]
15. Chronotherapy of hypertension: administration-time-dependent effects of treatment on the circadian pattern of blood pressure.
Hermida RC; Ayala DE; Calvo C; Portaluppi F; Smolensky MH
Adv Drug Deliv Rev; 2007 Aug; 59(9-10):923-39. PubMed ID: 17659803
[TBL] [Abstract][Full Text] [Related]
16. Chronotherapeutics: the relevance of timing in cancer therapy.
Lévi F
Cancer Causes Control; 2006 May; 17(4):611-21. PubMed ID: 16596317
[TBL] [Abstract][Full Text] [Related]
17. Modeling oxaliplatin drug delivery to circadian rhythms in drug metabolism and host tolerance.
Clairambault J
Adv Drug Deliv Rev; 2007 Aug; 59(9-10):1054-68. PubMed ID: 17707544
[TBL] [Abstract][Full Text] [Related]
18. [Recent data in chronopharmacokinetics].
Bruguerolle B
Pathol Biol (Paris); 1987 Jun; 35(6):925-34. PubMed ID: 3306573
[TBL] [Abstract][Full Text] [Related]
19. A cell cycle automaton model for probing circadian patterns of anticancer drug delivery.
Altinok A; Lévi F; Goldbeter A
Adv Drug Deliv Rev; 2007 Aug; 59(9-10):1036-53. PubMed ID: 17692993
[TBL] [Abstract][Full Text] [Related]
20. Distinct circadian time structures characterize myeloid and erythroid progenitor and multipotential cell clonogenicity as well as marrow precursor proliferation dynamics.
Wood PA; Hrushesky WJ; Klevecz R
Exp Hematol; 1998 Jun; 26(6):523-33. PubMed ID: 9620286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
